ICE: COVID-19 in Polish Ice Swimmers.

Sponsor
Wroclaw Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04817280
Collaborator
(none)
2,534
3
3
844.7
285.7

Study Details

Study Description

Brief Summary

Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.

Condition or Disease Intervention/Treatment Phase
  • Other: Ice Swimming

Detailed Description

The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.

The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.

Study Design

Study Type:
Observational
Actual Enrollment :
2534 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
Actual Study Start Date :
Dec 1, 2020
Actual Primary Completion Date :
Jan 17, 2021
Actual Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Ice Swimmers Group.

No intervention. Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.

Other: Ice Swimming
The intervention is not made in the course of a research study. Ice swimming has been introduced earlier by a given group. The group was made up of people who already swim in ice.

Outcome Measures

Primary Outcome Measures

  1. Assessment of the incidence of COVID-19 among ice swimmers compared to the general population. [47 days.]

    Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.

  2. Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population. [47 days.]

    Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.

  3. Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population. [47 days.]

    Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.

  4. Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population. [47 days.]

    Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.

  5. Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course. [47 days.]

    Inference from data obtained from surveys collected among ice swimmers.

  6. Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers. [47 days.]

    Inference from data obtained from surveys collected among ice swimmers.

Secondary Outcome Measures

  1. Assessment of the immunity of the ice swimmer's immune system compared to the general population. [47 days.]

    Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ice swimmers
Exclusion Criteria:
  • not active ice swimmers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Public Health at Wroclaw Medical University Wrocław Dolny Slask Poland 51-618
2 Department of Radiotherapy of Multidisciplinary Provincial Hospital Gorzów Wielkopolski Lubuskie Poland 66-400
3 Treasury Medical Company Zielona Góra Lubuskie Poland 65-031

Sponsors and Collaborators

  • Wroclaw Medical University

Investigators

  • Study Director: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
  • Study Director: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
  • Study Chair: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
  • Principal Investigator: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
  • Principal Investigator: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wroclaw Medical University
ClinicalTrials.gov Identifier:
NCT04817280
Other Study ID Numbers:
  • KB-03/139/2021
First Posted:
Mar 26, 2021
Last Update Posted:
Apr 9, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wroclaw Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 9, 2021